- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04906018
A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
The American Society of Regional Anesthesia and Pain Medicine (ASRA) has published evidence-based assessment of ultrasound-guided regional anesthesia (Neal et al., 2010) concluding that ultrasound guidance is superior or equal to other non-ultrasound nerve localization techniques. A subsequent publication from ASRA (Neal et al., 2016), has strengthened their position of ultrasound guidance being superior than other methods, including for the reduction of local anesthetic systemic toxicity. However, ultrasound-guided regional anesthesia (UGRA) is a difficult technique to master. A key activity of UGRA is ultrasound image interpretation (Sites et al., 2009) which ScanNav Anatomy PNB is designed to support. The data collected during this study will be assessed by a panel of intended users (experts in UGRA) to evaluate the performance and safety of ScanNav Anatomy PNB device highlighting.
Statistical Methodology:
Validation analyses will be conducted once the data collection has been complete. The collected scans will be processed, and the device output will be generated post hoc. Device output will be presented with raw ultrasound side-by-side. A panel of at least three expert anesthesiologists will review and evaluate each processed scan. The majority view of the panel will be used to evaluate each endpoint for any given structure ScanNav Anatomy PNB is intended to highlight.
Data collection and scan processing:
40 different subjects will be scanned. The dataset will be balanced to contain approximately equal numbers of subjects with BMI<30 and BMI>= 30 kg/m2.
All data collection will be performed with FDA cleared general purpose ultrasound machine, ScanNav Anatomy PNB device will not be used during data collection.
Data characteristics for scan subjects (e.g., age and BMI) will be reported. Ultrasound scans for all 9 supported anatomical regions will be collected from both sides of each subject.
90 x 10s clips per supported anatomical region will be generated, consisting of:
- 80 x 10s scene clips: the block view (chosen by the expert scanner) together with the preceding 10 seconds of ultrasound scanning will be recorded (without the use of ScanNav Anatomy PNB)
- 10 x 10s non-scene clips: 10 second ultrasound scans will be recorded at non-optimum block views, chosen by the expert scanner to represent plausible scanning errors (without the use of ScanNav Anatomy PNB) Scenes and non-scenes will be analyzed separately. Unmodified ultrasound video and highlighted video (color overlay produced by ScanNav Anatomy PNB generated post-hoc) will be presented side-by-side to independent experts for data analysis.
Data analysis:
Every clip will be presented to a minimum of 3 independent expert reviewers. All clips from a single anatomical region will be reviewed by the same 3 reviewers. Experts may review more than one anatomical region, but not necessarily all anatomical regions. Thus, a range of experts will review all anatomical regions.
Reviewers will be asked structured questions to assess the highlighting of safety critical anatomical structures (see definitions later in document) and the performance of ScanNav Anatomy PNB output for each individual clip.
The majority opinion (at least 2/3) will be obtained to establish the overall panel opinion (e.g., yes/yes/no = yes) for each structure on each clip.
Data will be evaluated and presented by structure in each anatomical region and overall (i.e., total for each class; nerve, artery etc.).
Inter-rater agreement between the reviewers will be reported on an anatomical region basis.
Data will be presented as frequencies and presented as percent of total clips analyzed.
Data analysis will include stratification by subject age, BMI, and ultrasound machine to ensure consistency across these variables.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or female, at least 18 years of age;
- Able to comprehend and sign the Informed Consent prior to enrolment in the study.
- Vaccinated against SARS-CoV-2
Exclusion Criteria:
- Aged <18 years of age;
- Unwilling or unable to provide informed consent.
- BMI> 39 kg/m2
- Known pathology of the area to be scanned
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
volunteer group - BMI less than 30
Each subject with a BMI less than 30 will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
volunteer group - BMI of 30 and above
Each subject with a BMI of 30 and above will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ScanNav Anatomy PNB highlighting misidentification of structures
Time Frame: 6 months
|
Frequency of misidentification of structures [% of total, per anatomical region]
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ScanNav Anatomy PNB highlighting identification of structures
Time Frame: 6 months
|
Frequency of correct identification of structures [% of total] and Frequency of non-identification of structures [% of total]
|
6 months
|
ScanNav Anatomy PNB safety issues
Time Frame: 6 months
|
Frequency of safety issues [% of total]
|
6 months
|
ScanNav Anatomy PNB adverse events
Time Frame: 6 months
|
Frequency of highlighting risking an adverse event [% of total]
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Glenn Woodworth, MD, Oregon Health and Science University
- Principal Investigator: James Bowness, MD, University of Oxford & Royal Gwent Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IU2021_AG_07
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ultrasound Imaging of Anatomical Structures
-
Medaphor LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
IntelligentUltrasound LimitedUniversity of OxfordActive, not recruitingUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
IntelligentUltrasound LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited States
-
IntelligentUltrasound LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
Medaphor LimitedIntelligentUltrasound LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
IntelligentUltrasound LimitedCompletedAn Evaluation of the Long-Term Impact of Assistive AI on Anaesthetists' Ultrasound Scanning for UGRAUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
IntelligentUltrasound LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
IntelligentUltrasound LimitedCompletedUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
Smart Alfa Teknoloji San. ve Tic. A.S.Ankara UniversityCompletedUltrasound Imaging of Anatomical Structures | Nerve BlockTurkey
-
Smart Alfa Teknoloji San. ve Tic. A.S.Ankara UniversityCompletedMusculoskeletal Diseases | Ultrasound Imaging of Anatomical StructuresTurkey
Clinical Trials on Ultrasound scans
-
Smart Alfa Teknoloji San. ve Tic. A.S.Ankara UniversityCompletedUltrasound Imaging of Anatomical Structures | Nerve BlockTurkey
-
IntelligentUltrasound LimitedCompleted
-
IntelligentUltrasound LimitedCompleted
-
Boston Children's HospitalRecruitingAspiration Pneumonia | Fasting | Delayed Gastric Emptying | Respiratory Aspiration of Gastric ContentUnited States
-
IntelligentUltrasound LimitedUniversity of OxfordActive, not recruitingUltrasound Imaging of Anatomical StructuresUnited Kingdom
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
EgymedicalpediaCompleted
-
FLUIDDA nvTerminatedBronchiolitis Obliterans | Lung Transplant RejectionBelgium
-
National Cancer Institute (NCI)CompletedNeurofibromatosis | MPNSTUnited States